[144] ZoomInfo Technologies Inc. SEC Filing

Rhea-AI Filing Summary

ZoomInfo Technologies Inc. insider filing reports a proposed sale of 14,290 common shares under Rule 144 through Morgan Stanley Smith Barney LLC on 10/02/2025, with an aggregate market value of $146,758.30 based on outstanding common shares of 318,630,783. The shares were acquired as Restricted Stock Units on 10/01/2025 and show a same-day acquisition and proposed sale timing. The filing identifies prior 10b5-1 sales by James M. Roth on 09/03/2025 of 3,288 shares for gross proceeds of $33,731.59. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Timely disclosure of proposed sale through Rule 144 via an established broker
• Inclusion of 10b5-1 history (prior sale of 3,288 shares) provides trading transparency

Negative

• Insider sale of 14,290 shares valued at $146,758.30 could be viewed unfavorably by some investors
• Same-day acquisition and proposed sale (acquired 10/01/2025; proposed sale 10/02/2025) may raise questions about timing

Insights

Insider Transactions Analyst

Insider plans to sell 14,290 shares, totaling $146,758.30.

The filing documents a proposed Rule 144 sale of 14,290 shares via Morgan Stanley Smith Barney on 10/02/2025. The shares were reported as acquired on 10/01/2025 as Restricted Stock Units, indicating recent vesting.

This notice also records prior 10b5-1 sales of 3,288 shares on 09/03/2025 for $33,731.59, showing recent execution activity. The filing itself is procedural disclosure required under securities rules.

Securities Compliance Officer

Filing includes the required attestation about material information and a trading-plan reference.

The form contains the standard representation that the seller does not possess undisclosed material adverse information and references Rule 10b5-1 sales, which aligns with compliance protocols for planned insider sales.

No statements in the filing assert any undisclosed material facts; the document fulfills statutory notice obligations for the proposed transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14290	146758.30	318630783	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Units	Issuer			14290	10/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES M ROTH 330 W Columbia Way, Floor 8 Vancouver WA 98660	COMMON	09/03/2025	3288	33731.59

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ZoomInfo (GTM) report?

The filing reports a proposed Rule 144 sale of 14,290 common shares through Morgan Stanley Smith Barney on 10/02/2025 valued at $146,758.30.

Who is the seller named in the Form 144?

The filing references sales for James M. Roth, including prior 10b5-1 sales on 09/03/2025 of 3,288 shares.

When were the shares to be sold acquired?

The shares were acquired as Restricted Stock Units on 10/01/2025, with the proposed sale dated 10/02/2025.

How many common shares are outstanding according to the filing?

The filing lists 318,630,783 common shares outstanding.

Does the Form 144 indicate undisclosed material information?

The seller represents in the notice that they do not know of any material adverse information not publicly disclosed.